China’s New COVID-19 Drug Ready For Use

By Lars James Hamer, December 24, 2021

0 0

China’s own antibody therapy for treatment against COVID-19 could be used domestically in clinical treatments as early as a few weeks. 

The drug was granted approval on December 8 based on the results of an international clinical trial involving over 800 patients. 

Read more New COVID-19 Drug Authorized for Use in China

The drug, which is administered via injection, could reduce the risk of hospitalization and death by around 80%, as reported by China Daily

However, there is no evidence that the new antibody therapy will work against Omicron or other variants of the virus. 

One of the benefits of the antibody therapy is that it will offer protection for those who are unvaccinated against COVID-19. 

[Cover image via Weibo

0 User Comments

In Case You Missed It…

We're on WeChat!

Scan our QR Code at right or follow us at Thats_Shanghai for events, guides, giveaways and much more!

7 Days in Shanghai With

Weekly updates to your email inbox every Wednesday


Download previous issues

Never miss an issue of That's Shanghai!

Visit the archives